Clinical trials
Prostatic Neoplasms, Castration-Resistant trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
| Active, not recruiting | 3 |
| Terminated | 3 |
| Completed | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 4 |
| MacroGenics | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 1 |
| British Columbia Cancer Agency | 1 |
| Endocyte | 1 |
| Hoffmann-La Roche | 1 |
| Janux Therapeutics | 1 |
| Leiden University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms, Castration-Resistant | 19 |
| Prostatic Neoplasms | 6 |
| Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Genital Diseases, Male | 2 |
| Genital Neoplasms, Male | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
| Neoplasms by Site | 2 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.